Allogenic stem cell transplant can cure high-risk CLL

Submitted by Ross Bonander Thu 07/15/2010

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Although most cases of small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) are considered indolent and can be effectively treated with chemotherapy, some patients do not respond to traditional treatments. These patients are considered high-risk, and in them the disease can be fatal within just a few years.

To address this group of patients, the German CLL Study Group (GCLLSG) undertook a multicenter (16) clinical phase II study that included 90 patients with high-risk SLL/CLL. In this so-called CLL3X trial, all patients received pre-transplant chemotherapy followed by an allogenic stem cell transplant. Findings indicated that, at a median follow-up of four years, approximately half of the cohort was disease-free, leading the study's authors to conclude that this treatment has the potential to cure some patients in the high-risk group.

TREATMENT TYPE

Allogenic stem cell transplant. In this treatment, the patient receives stem cells from a matching donor.

WHERE WAS THIS RESEARCH PUBLISHED?

Online in the journal Blood.

By Ross Bonander

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.